VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $12,000 | +50.0% | 500 | -28.6% | 0.00% | +50.0% |
| Q1 2017 | $8,000 | -20.0% | 700 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $10,000 | -41.2% | 700 | 0.0% | 0.00% | -40.0% |
| Q3 2016 | $17,000 | +6.2% | 700 | -9.7% | 0.01% | 0.0% |
| Q2 2016 | $16,000 | -20.0% | 775 | 0.0% | 0.01% | -37.5% |
| Q1 2016 | $20,000 | -33.3% | 775 | +158.3% | 0.01% | -27.3% |
| Q4 2015 | $30,000 | +66.7% | 300 | +200.0% | 0.01% | +57.1% |
| Q3 2015 | $18,000 | -18.2% | 100 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $22,000 | -45.0% | 100 | -50.0% | 0.01% | -42.9% |
| Q1 2015 | $40,000 | +185.7% | 200 | +100.0% | 0.01% | +180.0% |
| Q4 2014 | $14,000 | +7.7% | 100 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $13,000 | – | 100 | – | 0.01% | – |
| Q2 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2014 | $13,000 | +8.3% | 100 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $12,000 | +20.0% | 100 | 0.0% | 0.01% | +25.0% |
| Q3 2013 | $10,000 | +11.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $9,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |